References
- Ulcickas Yood M, Oliveria S, Cziraky M, . Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012;28:213-19
- Karve S, Cleves M, Helm M, . An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008;46:1125-33
- Hess L, Raebel M, Conner D, . Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8
- Partridge A, Avorn J, Wang P, . Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002;94:652-61
- Partridge A, Wang P, Winer E, . Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602-6
- Cox DR. Regression models, life-tables. With discussion by F. Downton, Richard Peto, D.J. Bartholomew, D.V. Lindley, P.W. Glassborow, D.E. Barton, Susannah Howard, B. Benjamin, John J. Gart, L.D. Meshalkin, A.R. Kagan, M. Zelen, R.E. Barlow, Jack Kalbfleisch, R.L. Prentice and Norman Breslow, and a reply by D.R. Cox. Stat Soc Ser B 1972;34:187-20
- Cramer J, Roy A, Burrell A, . Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7
- Marin D, Bazeos A, Mahon F, . Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol 2010;28:2381-8
- Ibrahim A, Eliasson L, Apperley J, . Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood 2011;117:3733-6
- Noens L, van Lierde M, De Bock R, . Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 2009;113:5401-11
- Ganesan P, Sagar T, Dubashi B, . Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol 2011;86:471-4